Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedStudy Start
First participant enrolled
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedMarch 20, 2024
March 1, 2024
11 months
January 12, 2023
March 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scapular retraction strength
Assess scapular retraction strength with a dynamometer
8 weeks
Secondary Outcomes (1)
One repetition maximum (1RM)
8 weeks
Other Outcomes (1)
Length for the pectoralis minor
8 weeks
Study Arms (2)
Myofascial Release
EXPERIMENTALThe Experimental group will receive a myofascial release pectoralis minor release intervention.
Sham Myofascial Release
SHAM COMPARATORThe Control group will receive a sham myofascial release pectoralis minor release intervention.
Interventions
Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
Eligibility Criteria
You may qualify if:
- Healthy individuals between the age of 18 and 30
You may not qualify if:
- Individuals with uncontrolled high blood pressure
- Individuals with sickle cell anemia, current pregnancy
- Individuals with a history of deep vein thrombosis
- Individuals with diabetes
- Individuals with active infection
- Individuals with less than normal range of motion or muscle strength
- Individuals with moderate to severe upper extremity injury in the past 12 months
- Individuals with a current diagnosis of cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Tennessee Health Science Center
Memphis, Tennessee, 38163, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The control group will receive a sham intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 12, 2023
First Posted
February 2, 2023
Study Start
October 16, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
March 20, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share